Physician

David A Laub, M.D.

According to 2025 Medicare claims, David Laub, M.D. (NPI: 1013187764) practices dermatology in the San Rafael, CA market, with the plurality of this provider's patient population coming from Marin, CA. This provider's primary affiliated billing organization is DAVID A LAUB MD, A PROFESSIONAL CORPORATION (NPI: 1366556797; TIN: 94-3389324) and primary practice location at 94941-6003.

Laub's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 876 traditional Medicare patients, billed 8,203 HCPCS/CPT codes, and received $562,163 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 666 prescription claims across 276 beneficiaries totaling $92,492 in drug costs, led by Otezla (Apremilast). Open Payments data shows 24 records totaling $1,365. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $62,173 to $92,492. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$356K$713K2015 Medicare payment: $482,803 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $419,658 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $364,745 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $510,031 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $712,556 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $549,854 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $628,945 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $524,760 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $540,675 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $562,163 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201597910,225$482,803
20169549,797$419,658
20179578,855$364,745
20189869,843$510,031
20191,00012,354$712,556
20209309,366$549,854
20219009,671$628,945
20229038,099$524,760
20238828,721$540,675
20248768,203$562,163

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$46K$92K2015 Drug cost: $62,173 (USD; Tot_Drug_Cst)2016 Drug cost: $48,666 (USD; Tot_Drug_Cst)2017 Drug cost: $34,417 (USD; Tot_Drug_Cst)2018 Drug cost: $24,013 (USD; Tot_Drug_Cst)2019 Drug cost: $27,316 (USD; Tot_Drug_Cst)2020 Drug cost: $36,059 (USD; Tot_Drug_Cst)2021 Drug cost: $30,173 (USD; Tot_Drug_Cst)2022 Drug cost: $19,653 (USD; Tot_Drug_Cst)2023 Drug cost: $33,962 (USD; Tot_Drug_Cst)2024 Drug cost: $92,492 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015218592$62,173
2016266652$48,666
2017252568$34,417
2018198428$24,013
2019261557$27,316
2020320834$36,059
2021358917$30,173
2022295735$19,653
2023290673$33,962
2024276666$92,492

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths468674$111
11102Biopsy of related skin growth, first growth401530$74
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more549804$73
88305Pathology examination of tissue using a microscope, intermediate complexity403781$70
17000Destruction of precancer skin growth, 1 growth553860$41

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OtezlaApremilast17630$76,343
ValacyclovirValacyclovir Hcl732,908$2,877
FluocinonideFluocinonide501,575$1,843
Triamcinolone AcetonideTriamcinolone Acetonide1284,948$1,282
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip381,132$1,187

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.24$1,365Galderma Laboratories, L.P.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for David A. Laub, M.D.?

Tedicare shows public-source Medicare data for David A. Laub, M.D. (NPI 1013187764), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David A. Laub, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to David A. Laub, M.D.?

David A. Laub, M.D. is linked to DAVID A LAUB MD, A PROFESSIONAL CORPORATION (billing NPI 1366556797) in the available physician profile data.

Does David A. Laub, M.D. have Open Payments data?

David A. Laub, M.D. has 24 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.